期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(99)Tc^m标记"3+1"混配放射性药物设计及进展 被引量：2

Resent Development of ^(99)Tc^m Labeled Radiopharmaceuticals With "3+1" Mixed-ligand
下载PDF
导出
摘要 介绍了"3+1"混配配合物的概念、结构、制备,详细论述了99Tcm标记的"3+1"混配配合物目前的进展,并对其存在的问题进行了讨论。 The resent development of '3+1' mixedligand labeled with 99Tcm is reviewed, and the disadvantages in the researching of which are discussed.
作者 唐秀欢 王武尚
机构地区 西北核技术研究所九室
出处 《同位素》 CAS 2002年第4期219-228,共10页 Journal of Isotopes
关键词 标记 药物设计 受体放射性药物 锝99 放射性同位素 ^(99)Tc^m labeling '3+1' mixed-ligand radiopharmaceuticals
分类号 R817.9 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献44

  • 1王世真.受体学是核医学研究的重要方向[J].中华核医学杂志,1997,17:197-197.
  • 2Jurisson SS, John DL. Potential Technetium Small Molecule Radiopharmaceuticals[J]. Chem Rev,1999, 99:2 205～2 218.
  • 3贾红梅,刘伯里.^(99)Tc^m标记的中枢神经系统受体放射性药物的设计方法及进展[J].同位素,2001,14(2):95-106. 被引量：3
  • 4Hirsch KM, Nicholson T, Davison A, et al. Synthesis and Characterization of Rhenium(Ⅲ) and Technetium(Ⅲ) Organohydrazide Chelate Complexes. Reactions of 2-Hydrazinopyridine With Complexes of Rhenium and Technetium[J]. Inorg Chem ,1997, 36(15):3 237～3 241.
  • 5Schibli R, Karra SR, Katti KV, et al. In Vitro and in Vivo Characterization of a Novel Bifunctionlized Water-soluble Dithia-bisphosphine 99Tcm-complex[J]. Radiochim Acta, 1998, 83:211～215.
  • 6Papagiannopoulou D, Pirmettis I, Maina T, et al. Development of Novel Mixed-ligand Oxotechnetium [SNS/S] Complexes as Potential 5-HT1A Receptor Imaging Agents[J]. J Biol Inorg Chem, 2001, 6(3):256～265.
  • 7Papadopoulos MS, Pelecanou M, Pirmettis IC, et al. A New Donor Atom System [(SNN)(S)] for the Synthesis of Neutral Oxotechnetium(V) Mixed-Ligand Complexes[J]. Inorg Chem, 1996, 35(15):4 478～4 483.
  • 8Pirmettis IC, Papadopoulos MS, Mastrostamatis SG, et al. Synthesis and Characterization of Oxotechnetium(V) Mixed-Ligand Complexes Containing a Tridentate N-Substituted Bis(2-mercaptoethyl)amine and a Monodentate Thiol[J]. Inorg Chem, 1996, 35(6):1 685～1 691.
  • 9Johannsen B, Scheunemann M, Spies H, et al. Technetium (V) and Rhenium(V) Complexes for 5-HT2A Serotonin Receptor Binding: Structure-affinity Considerations[J]. Nucl Med Biol, 1996, 23:429～438.
  • 10Seifert S, Pietzsch H-J, Scheunemann M, et al. No Carrier Added Preparation of "3+1" Mixed-ligand 99Tcm Complexes[J]. Appl Radiat Isot, 1998, 49(2):5～11.

二级参考文献24

  • 1沈鸣华,龚佳玲,王蔷,朱桐,刘伯里,孟昭兴,唐志刚.多巴胺D_2受体拮抗剂氨基取代苯酰胺类化合物的合成[J].核技术,1995,18(11):651-654. 被引量：5
  • 2沈粹卿,刘飚.硫酸生产企业的安全评价[J].硫酸工业,2006(4):8-13. 被引量：7
  • 3小川纪雄 冯剑波（译）.脑受体[M].北京:北京医科大学、中国协和医科大学联合出版社,1997.314-359.
  • 4潘中允.临床核医学[M].北京:原子能出版社,1999.123-124.
  • 5张春艳.多巴胺转运蛋白显像剂的研究[M].北京:北京师范大学化学系,2001..
  • 6Liu Xiojie，Clinical nuclear medicine in cardiovascular and pulmonary diseases （inChinese），1993年，66,111页
  • 7Wang Xuebin，同位素，1996年，9卷，4期，193页
  • 8Miao Y，Proceedings of 5th Int Symposium on Chemistry in Technetium and Nuclear Medicine，1998年，682页
  • 9Nock B A，J Med Chem，1999年，42卷，1066页
  • 10潘中允，临床核医学，1999年，123页

共引文献10

同被引文献27

  • 1PIRMETTIS I C,PAPADOPOULOS M S, CHIO-TELLIS E. Novel 99^Tc^m Aminobisthiolato/monothi-olato “3 + 1” Mixed Ligand Complexes: Structureactivity Relationships and Preliminary in vivo Validation as Brain Blood Flow Imaging Agents [J]. J Med Chem, 1997,40(16):2 539-2 546.
  • 2TSOUKALAS C, PAPADOPOULOS M S, MAINA T ,et al. Characterization and Preliminary Evaluation of Ester-modified Technetium-99m SNS/SMixed Ligand Complexes as Potential Brain Perfusion Agents[J]. Nucl Med Biol, 1999,26(3) :297-304.
  • 3MASTROSTAMATIS S G, PAPADOPOULOS MS, PIRMETTIS I C, et al. Tridentate Ligands Containing the SNS Donor Atom Set as a Novel Backbone for the Development of Technetium Brain-imaging Agents[J]. J Med Chem, 1994,37(20):3 212-3 218.
  • 4MIAO Yu-bin, LIU Bo-li. Technetium-99m-MPBDA, a New Potential Cerebral and Myocardial Perfusion Imaging Agent: in vlvo Biodistribution in Mice[A]. In: NICOLINI M, MAZZI U, ed. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine[C]. Italy: SGE Editoriali,1999. 681-685.
  • 5MIAO Yu-bin, LIU Bo-li. Technetium-99m-MPBDA, a New Potential Cerebral Perfusion Imaging Agent: SPECT Studies in Monkey[A]. In : NICOLINIM, MAZZI U, ed. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine[C].Italy:SGE Editoriali, 1999. 819-823.
  • 6BOSCHI A,BOLZATI C,UCCELLI L,et al.A Class of Asymmetrical Nitrido Technetium-99m Heterocomplexes as Heart Imaging Agents With Improved Biological Properties[J].Nucl Med Commum,2002,23:689-693.
  • 7PIETZSCH HJ,SPIES H,HAFFMANN S.Lipophilic Technetium Complexes.VI.Neutral Oxotechnetium(V) Complexes With Tridentate Dithiole/monothiole Ligand Coordination[J].Inorg Chim Acta,1989,165:163-166.
  • 8WüST F,CARLSON KE,KATZENELLENBOGEN JA,et al.Synthesis and Binding Affinities of New 17a-substituted Estradiol-Rhenium "n+ 1" Mixed-ligand and Thioethercarbonyl Complexes[J].Steroids,1998,63:665-671.
  • 9SPIES H,FIETZ H,GLASER M,et al.The "n +1" Concept in the Synthesis Strategy of Novel Technetium and Rhenium Tracers[C]// Nicolini M,Bandoli G,Mazzi U,eds.Technetium and Rhenium in Chemistry and Nuclear Medicine 4.Italy,Padova:SGEditoriali,1995:243-246.
  • 10MEEGALLA SK,PLOèSSL K,KUNG M-P,et al.The First Example of a Tc-99m Complex as a Dopamine Transporter Imaging Agent[J].J Am Chem Soc,1995,117:11 037 -11 038.

引证文献2

同位素
2002年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部